Related references
Note: Only part of the references are listed.Development and validation of a novel UPLC-MS/MS method for quantification of delafloxacin in plasma and aqueous humour for pharmacokinetic analyses
Muzaffar Igbal et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2020)
Sustained release and enhanced oral bioavailability of rivaroxaban by PLGA nanoparticles with no food effect
Md Khalid Anwer et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats
Khalid Anwer et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives
Anubhab Mukherjee et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
Manuel Lopez-Lopez et al.
PHARMACEUTICS (2019)
Chitosan surface modified PLGA nanoparticles loaded with brigatinib for the treatment of non-small cell lung cancer
Muqtader Mohammed et al.
JOURNAL OF POLYMER ENGINEERING (2019)
Clinical Pharmacokinetics and Pharmacodynamics of Delafloxacin
Jennifer Shiu et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2019)
Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin
Muhammad Muzamil Khan et al.
DRUG DELIVERY (2019)
What Is Old Is New Again: Delafloxacin, a Modern Fluoroquinolone
Jonathan C. Cho et al.
PHARMACOTHERAPY (2018)
Mucoadhesive chitosan-coated solid lipid nanoparticles for better management of tuberculosis
Alexandre C. C. Vieira et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin
Wei Dong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Clinical and pharmacokinetic drug evaluation of delafloxacin for the treatment of acute bacterial skin and skin structure infections
Matteo Bassetti et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
Md. K. Anwer et al.
FRONTIERS IN PHARMACOLOGY (2017)
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age
Randall Hoover et al.
CLINICAL THERAPEUTICS (2016)
Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers
Randall Hoover et al.
CLINICAL THERAPEUTICS (2016)
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs
Marco Falcone et al.
INTERNAL AND EMERGENCY MEDICINE (2016)
Community-Acquired Pneumonia Requiring Hospitalization among US Adults
S. Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Comparison of the Antibiotic Activities of Daptomycin, Vancomycin, and the Investigational Fluoroquinolone Delafloxacin against Biofilms from Staphylococcus aureus Clinical Isolates
Wafi Siala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin
Linlin Wang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Incidence, microbiology, and patient characteristics of skin and soft-tissue infections in a US population: a retrospective population-based study
Gary Thomas Ray et al.
BMC INFECTIOUS DISEASES (2013)
Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing
Itzhak Brook et al.
CLINICAL MICROBIOLOGY REVIEWS (2013)
Lipid Colloidal Carriers for Improvement of Anticancer Activity of Orally Delivered Quercetin: Formulation, Characterization and Establishing In Vitro-In Vivo Advantage
Ankitkumar S. Jain et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2013)
Activity of delafloxacin against methicillin-resistant Staphylococcus aureus: resistance selection and characterization
Joan M. Remy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Contrasting Effects of Acidic pH on the Extracellular and Intracellular Activities of the Anti-Gram-Positive Fluoroquinolones Moxifloxacin and Delafloxacin against Staphylococcus aureus
Sandrine Lemaire et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The roles of lipid in anti-biofilm efficacy of lipid-polymer hybrid nanoparticles encapsulating antibiotics
Wean Sin Cheow et al.
COLLOIDS AND SURFACES A-PHYSICOCHEMICAL AND ENGINEERING ASPECTS (2011)
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harshad Harde et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
Liangfang Zhang et al.
ACS NANO (2008)
Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
Irith Wiegand et al.
NATURE PROTOCOLS (2008)
Formation of self-organized nanoparticles by lecithin/chitosan ionic interaction
F. Sonvico et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Quinolones in 2005: an update
F Van Bambeke et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Dual activity of fluoroquinolones against Streptococcus pneumoniae:: the facts behind the claims
HJ Smith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Patient compliance with antibiotic treatment for respiratory tract infections
P Kardas
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Share Paper
